A 9-BP DELETION (2320DEL9) ON THE BACKGROUND OF THE ARYLSULFATASE-A PSEUDODEFICIENCY ALLELE IN A METACHROMATIC LEUKODYSTROPHY PATIENT AND IN A PATIENT WITH NONPROGRESSIVE NEUROLOGICAL SYMPTOMS
S. Regis et al., A 9-BP DELETION (2320DEL9) ON THE BACKGROUND OF THE ARYLSULFATASE-A PSEUDODEFICIENCY ALLELE IN A METACHROMATIC LEUKODYSTROPHY PATIENT AND IN A PATIENT WITH NONPROGRESSIVE NEUROLOGICAL SYMPTOMS, Human genetics, 102(1), 1998, pp. 50-53
A 9-bp deletion (2320del9) was detected in the arylsulfatase A genes o
f a patient with late infantile metachromatic leukodystrophy and of a
patient with nonprogressive neurological symptoms and very low arylsul
fatase A activity. Both patients are heterozygous for the deletion, wh
ich involves codons 406-408 and causes loss of a Ser-Asp-Thr tract-in
the predicted protein, Tn both patients the 9-bp deletion lies in a ps
eudodeficiency; allele., The patient with metachromatic leukodystrophy
carries the common 459 + 1G > A mutation in the other allele, The oth
er patient is homozygous for the pseudodeficiency allele, and conseque
ntly is a compound heterozygote for a metachromatic leukodystrophy all
ele and a pseudodeficiency allele. ,We hypothesize that the compound h
eterozygosity predisposes to the development of nonprogressive neurolo
gical symptoms in the presence of additional, still unknown, genetic o
r nongenetic factors.